New RE-VERSE AD™ analyses provide additional insights on impact of Praxbind® (idarucizumab
Additional analyses of patients in diverse emergency settings confirm that idarucizumab immediately reverses the anticoagulant effect of dabigatran in patients in emergency settings1,2 Sub-analyses from RE-VERSE AD, the largest study to investigate INGELHEIM,